(Q38183707)

30 August 2017

title

Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate (English)

1 reference

head and neck squamous cell carcinoma

30 August 2017

main subject

1 reference

3

Avraham Eisbruch

1 reference

30 August 2017

2

June Corry

1 reference

30 August 2017

9

Remco de Bree

1 reference

30 August 2017

16

Alessandra Rinaldo

1 reference

30 August 2017

17

Alfio Ferlito

1 reference

30 August 2017

10

Robert P Takes

1 reference

30 August 2017

5

William M Mendenhall

1 reference

30 August 2017

4

Jan B Vermorken

1 reference

30 August 2017

14

Carol R Bradford

1 reference

30 August 2017

8

Jonathan J Beitler

1 reference

30 August 2017

15

Louis B Harrison

1 reference

30 August 2017

7

Missak Haigentz

1 reference

30 August 2017

Primož Strojan

1

1 reference

30 August 2017

Anne W M Lee

6

1 reference

30 August 2017

Vinidh Paleri

11

1 reference

30 August 2017

Charles G Kelly

12

1 reference

30 August 2017

Eric M Genden

13

1 reference

30 August 2017

publication date

31 January 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

37

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

134-150

1 reference

Intraoperative high-dose-rate radiotherapy in the management of locoregionally recurrent head and neck cancer

30 August 2017

cites work

1 reference

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.

21 January 2018

1 reference

Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas

21 January 2018

1 reference

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

21 January 2018

1 reference

Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck

21 January 2018

1 reference

Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience

21 January 2018

1 reference

Salvage surgery with free flap reconstruction: factors affecting outcome after treatment of recurrent head and neck squamous carcinoma

21 January 2018

1 reference

Platinum-based chemotherapy plus cetuximab in head and neck cancer

21 January 2018

1 reference

Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.

21 January 2018

1 reference

Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: a decision analysis model based on a systematic review

21 January 2018

1 reference

Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma

21 January 2018

1 reference

Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma

21 January 2018

1 reference

Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer

21 January 2018

1 reference

Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma.

21 January 2018

1 reference

Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma

21 January 2018

1 reference

Reirradiation after salvage surgery and microvascular free flap reconstruction for recurrent head and neck carcinoma

21 January 2018

1 reference

Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent

21 January 2018

1 reference

Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy

21 January 2018

1 reference

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients

21 January 2018

1 reference

Conformal re-irradiation of recurrent and new primary head-and-neck cancer

21 January 2018

1 reference

Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer

21 January 2018

1 reference

Chemo-reirradiation in persistent/recurrent head and neck cancers

21 January 2018

1 reference

A phase II study of primary reirradiation in squamous cell carcinoma of head and neck.

21 January 2018

1 reference

Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer

21 January 2018

1 reference

Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers

21 January 2018

1 reference

Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol

21 January 2018

1 reference

Outcome after re-irradiation of head and neck cancer patients.

21 January 2018

1 reference

Reirradiation with cetuximab in locoregional recurrent and inoperable squamous cell carcinoma of the head and neck: feasibility and first efficacy results

21 January 2018

1 reference

The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease

21 January 2018

1 reference

Postirradiation changes on the lymphatics studied by lymphography

21 January 2018

1 reference

Lymphangiographic changes after radiation therapy

21 January 2018

1 reference

Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma in the previously treated neck.

21 January 2018

1 reference

The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets

21 January 2018

1 reference

Screening for distant metastases in patients with head and neck cancer

21 January 2018

1 reference

Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer

21 January 2018

1 reference

Salvage re-irradiation for recurrent head and neck cancer

21 January 2018

1 reference

Outcomes following reirradiation of patients with head and neck cancer

21 January 2018

1 reference

IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.

21 January 2018

1 reference

Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.

21 January 2018

1 reference

Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.

21 January 2018

1 reference

Reirradiation with intensity-modulated radiotherapy in recurrent head and neck cancer

21 January 2018

1 reference

Prospective trial of high-dose reirradiation using daily image guidance with intensity-modulated radiotherapy for recurrent and second primary head-and-neck cancer.

21 January 2018

1 reference

Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck

21 January 2018

1 reference

Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen

21 January 2018

1 reference

Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation.

21 January 2018

1 reference

Elective neck dissection during salvage laryngectomy

21 January 2018

1 reference

Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer

21 January 2018

1 reference

Oncologic effectiveness of selective neck dissection in the N0 irradiated neck

21 January 2018

1 reference

Re-irradiation in the management of isolated neck recurrences: current status and recommendations

21 January 2018

1 reference

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

21 January 2018

1 reference

Radiation dose-volume effects in the spinal cord.

21 January 2018

1 reference

Update of human spinal cord reirradiation tolerance based on additional data from 38 patients

21 January 2018

1 reference

Dose sparing of brainstem and spinal cord for re-irradiating recurrent head and neck cancer with intensity-modulated radiotherapy

21 January 2018

1 reference

Regional cumulative maximum dose to the spinal cord in head-and-neck cancer: considerations for re-irradiation.

21 January 2018

1 reference

Risk of carotid blowout after reirradiation of the head and neck: a systematic review

21 January 2018

1 reference

Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.

21 January 2018

1 reference

Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region

21 January 2018

1 reference

Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.

21 January 2018

1 reference

Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: a randomized study.

21 January 2018

1 reference

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

21 January 2018

1 reference

A retrospective comparison of robotic stereotactic body radiotherapy and three-dimensional conformal radiotherapy for the reirradiation of locally recurrent nasopharyngeal carcinoma

21 January 2018

1 reference

Phase I trial of radiochemotherapy with bendamustine in patients with recurrent squamous cell carcinoma of the head and neck

21 January 2018

1 reference

Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer

21 January 2018

1 reference

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

Prospective evaluation of patient-reported quality-of-life outcomes following SBRT ± cetuximab for locally-recurrent, previously-irradiated head and neck cancer

21 January 2018

1 reference

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy

21 January 2018

1 reference

Surgical salvage of the oropharynx after failure of organ-sparing therapy

21 January 2018

1 reference

Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer

21 January 2018

1 reference

The role of elective neck dissection during salvage surgery in head and neck squamous cell carcinoma

21 January 2018

1 reference

Long-term outcome analysis after surgical salvage for recurrent tonsil carcinoma following radical radiotherapy

21 January 2018

1 reference

Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery

21 January 2018

1 reference

7 January 2021

Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites

1 reference

7 January 2021

Reirradiation of recurrent head and neck cancers

1 reference

7 January 2021

[Hyperfractionated reirradiation after salvage surgery in cervico-facial carcinoma. Result of a pilot study in 14 patients]

1 reference

7 January 2021

Intraoperative electron beam radiotherapy for previously irradiated advanced head and neck malignancies

1 reference

7 January 2021

Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911

1 reference

7 January 2021

The reirradiation of recurrences of head and neck cancer

1 reference

7 January 2021

Reirradiation of head and neck cancers. Presentation of 35 cases treated at the Gustave Roussy Institute

1 reference

7 January 2021

Re-irradiation of laryngeal carcinoma--techniques and results

1 reference

7 January 2021

High-dose reirradiation of head and neck cancer with curative intent

1 reference

7 January 2021

Pilot study for the evaluation of simultaneous cisplatin/5-fluorouracil infusion and limited radiation therapy in regionally recurrent head and neck cancer (EST P-C385)

1 reference

7 January 2021

Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck

1 reference

7 January 2021

Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study

1 reference

7 January 2021

Prognostic factors of reirradiation for recurrent head and neck cancer

1 reference

7 January 2021

Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies

1 reference

7 January 2021

Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer

1 reference

7 January 2021

Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial

1 reference

7 January 2021

Management of the N0 neck during salvage laryngectomy

1 reference

7 January 2021

Treatment of the N0 neck during salvage surgery after radiotherapy of head and neck squamous cell carcinoma.

1 reference

7 January 2021

Incidence of subclinical nodal disease at the time of salvage surgery for locally recurrent head and neck cancer initially treated with definitive radiation therapy

1 reference

7 January 2021

Elective neck dissection for second primary after previous definitive radiotherapy

1 reference

7 January 2021

Prognostic factors for survival after salvage reirradiation of head and neck cancer

1 reference

7 January 2021

Extent and kinetics of recovery of occult spinal cord injury

1 reference

7 January 2021

Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation

1 reference

7 January 2021

Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer

1 reference

7 January 2021

Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer

1 reference

7 January 2021

Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes

1 reference

7 January 2021

Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study

1 reference

7 January 2021

Salvage stereotactic reirradiation using the CyberKnife for the local recurrence of nasal or paranasal carcinoma

1 reference

7 January 2021

Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer

1 reference

7 January 2021

Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies

1 reference

7 January 2021

Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer

1 reference

7 January 2021

Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.23542

1 reference

30 August 2017

1 reference